Experimentation to favor innovation: Promoting the success of Article 51 transformation projects.
Article 51
Evaluation
Experimentation
Innovation
Organization
Journal
Therapie
ISSN: 0040-5957
Titre abrégé: Therapie
Pays: France
ID NLM: 0420544
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
06
11
2018
accepted:
12
11
2018
pubmed:
27
1
2019
medline:
18
12
2019
entrez:
27
1
2019
Statut:
ppublish
Résumé
Article 51 of the French social security financing act for 2018 creates a derogatory funding system to support experimentation with new ways of organizing care pathways. The growing interest local leaders have expressed for this very open framework has led to a large number of candidate projects presented to public authorities in charge of the system. In order to sustain this dynamic movement and favor the success of these experimental projects, our work focused on clarifying the roles and responsibilities of project leaders and the need for a specific evaluation system that takes into account the evolving nature of these projects and the need for operational adaptability. We propose three levels of evaluation (feasibility, intermediary results and impact assessment) needed to decide on generalizing a given experiment based on its intermediary results, or on the contrary, terminating projects not meeting feasibility expectations. Our work emphasizes the importance of networking and of developing favorable conditions for fruitful collaboration between participating stakeholders-healthcare professionals, health providers, economic partners, learned societies-interested in improving the performance of care pathways.
Identifiants
pubmed: 30683444
pii: S0040-5957(18)30258-0
doi: 10.1016/j.therap.2018.11.010
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
51-57Investigateurs
Jean Bourhis
(J)
Sandrine Bourguignon
(S)
Benoît Dervaux
(B)
Sophie Dubois
(S)
Isabelle Durand-Zaleski
(I)
Anne-Aurélie Epis de Fleurian
(AA)
Florence Favrel-Feuillade
(F)
Philippe Lechat
(P)
Philippe Maugendre
(P)
Bastien Mezerette
(B)
Dominique Polton
(D)
Xavier Pourrat
(X)
Informations de copyright
Copyright © 2018 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved.